Metraipolis › archive › dc_1458dd37c2bf

Efficacy and safety of efgartigimod in the treatment of impending myasthenic crisis — Europe PMC PMID:41909657

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41909657
DOI
10.3389/fimmu.2026.1760953
License (as archived)
solo-consultazione
Archived
2026-11-04T11:34:44.595Z
SHA-256 of the archived text
e5a2b9edd8a852ba8928e9d1db6641668fb81fc1a05aaf01b16d861e14c1698c
Stable URL of this page
https://metraipolis.com/documento/dc_1458dd37c2bf

How to cite

Efficacy and safety of efgartigimod in the treatment of impending myasthenic crisis — Europe PMC PMID:41909657 — Europe PMC (en), https://europepmc.org/article/MED/41909657 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1458dd37c2bf (Metraipolis archive dc_1458dd37c2bf, sha256 e5a2b9edd8a852ba8928e9d1db6641668fb81fc1a05aaf01b16d861e14c1698c)
BibTeX
@misc{dc1458dd37c2bf,
  title = {Efficacy and safety of efgartigimod in the treatment of impending myasthenic crisis — Europe PMC PMID:41909657},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41909657},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1458dd37c2bf; sha256 e5a2b9edd8a852ba8928e9d1db6641668fb81fc1a05aaf01b16d861e14c1698c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41909657. Agents can read the archived copy with the MCP tool read_document.